ANEMIA; HEMODIALYSIS DEPENDENT CHRONIC KIDNEY DISEASE
Clinical trials for ANEMIA; HEMODIALYSIS DEPENDENT CHRONIC KIDNEY DISEASE explained in plain language.
Never miss a new study
Get alerted when new ANEMIA; HEMODIALYSIS DEPENDENT CHRONIC KIDNEY DISEASE trials appear
Sign up with your email to follow new studies for ANEMIA; HEMODIALYSIS DEPENDENT CHRONIC KIDNEY DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill could rival standard anemia shot for dialysis patients
Disease control CompletedThis study tested a new drug, MT-6548, against a standard treatment (darbepoetin alfa) for anemia in people with chronic kidney disease who are on hemodialysis. The goal was to see if the new drug works just as well at keeping hemoglobin levels stable. 323 participants took part …
Matched conditions: ANEMIA; HEMODIALYSIS DEPENDENT CHRONIC KIDNEY DISEASE
Phase: PHASE3 • Sponsor: Tanabe Pharma Corporation • Aim: Disease control
Last updated May 17, 2026 08:51 UTC
-
New hope for dialysis patients: drug aims to fix anemia without injections
Disease control CompletedThis study tested a pill called MT-6548 in 24 adults in Japan who have anemia due to chronic kidney disease and are on hemodialysis. The goal was to see if the drug can safely raise and maintain their hemoglobin levels within a target range. Participants were not using other anem…
Matched conditions: ANEMIA; HEMODIALYSIS DEPENDENT CHRONIC KIDNEY DISEASE
Phase: PHASE3 • Sponsor: Tanabe Pharma Corporation • Aim: Disease control
Last updated May 06, 2026 16:03 UTC